Goodwill and Other Intangible Assets (Tables)
|
12 Months Ended |
Dec. 31, 2024 |
|---|
| Goodwill and Intangible Assets Disclosure [Abstract] |
|
| Schedule of Finite-Lived Intangible Assets |
The gross carrying amounts and accumulated amortization of the Company’s intangible assets with determinable lives as of December 31, 2024 and 2023 were as follows: | | | | | | | | | | | | | | | | | | | | | | | December 31, 2024 | | | Gross Carrying Amount | | Accumulated Amortization | | Net Carrying Amount | | | (in thousands) | | Finite-lived intangible assets: | | | | | | | | Customer relationships and licenses | | $ | 7,686 | | | $ | (2,681) | | | $ | 5,005 | | | Media brand | | 1,250 | | | (677) | | | 573 | | | Developed technology | | 1,073 | | | (732) | | | 341 | | | Trademarks | | 1,052 | | | (382) | | | 670 | | | | | | | | | | Total finite-lived intangible assets | | 11,061 | | | (4,472) | | | 6,589 | | | Indefinite-lived intangible assets | | 177 | | | — | | | 177 | | | Total intangible assets | | $ | 11,238 | | | $ | (4,472) | | | $ | 6,766 | |
| | | | | | | | | | | | | | | | | | | | | | | December 31, 2023 | | | Gross Carrying Amount | | Accumulated Amortization | | Net Carrying Amount | | | (in thousands) | | Finite-lived intangible assets: | | | | | | | | Customer relationships and licenses | | $ | 7,686 | | | $ | (1,550) | | | $ | 6,136 | | | Media brand | | 1,250 | | | (52) | | | 1,198 | | | Developed technology | | 1,073 | | | (479) | | | 594 | | | Trademarks | | 1,052 | | | (201) | | | 851 | | | Pharmacy board licenses | | 5 | | | (5) | | | — | | | Total finite-lived intangible assets | | 11,066 | | | (2,287) | | | 8,779 | | | Indefinite-lived intangible assets | | 49 | | | — | | | 49 | | | Total intangible assets | | $ | 11,115 | | | $ | (2,287) | | | $ | 8,828 | |
|
| Schedule of Indefinite-Lived Intangible Assets |
The gross carrying amounts and accumulated amortization of the Company’s intangible assets with determinable lives as of December 31, 2024 and 2023 were as follows: | | | | | | | | | | | | | | | | | | | | | | | December 31, 2024 | | | Gross Carrying Amount | | Accumulated Amortization | | Net Carrying Amount | | | (in thousands) | | Finite-lived intangible assets: | | | | | | | | Customer relationships and licenses | | $ | 7,686 | | | $ | (2,681) | | | $ | 5,005 | | | Media brand | | 1,250 | | | (677) | | | 573 | | | Developed technology | | 1,073 | | | (732) | | | 341 | | | Trademarks | | 1,052 | | | (382) | | | 670 | | | | | | | | | | Total finite-lived intangible assets | | 11,061 | | | (4,472) | | | 6,589 | | | Indefinite-lived intangible assets | | 177 | | | — | | | 177 | | | Total intangible assets | | $ | 11,238 | | | $ | (4,472) | | | $ | 6,766 | |
| | | | | | | | | | | | | | | | | | | | | | | December 31, 2023 | | | Gross Carrying Amount | | Accumulated Amortization | | Net Carrying Amount | | | (in thousands) | | Finite-lived intangible assets: | | | | | | | | Customer relationships and licenses | | $ | 7,686 | | | $ | (1,550) | | | $ | 6,136 | | | Media brand | | 1,250 | | | (52) | | | 1,198 | | | Developed technology | | 1,073 | | | (479) | | | 594 | | | Trademarks | | 1,052 | | | (201) | | | 851 | | | Pharmacy board licenses | | 5 | | | (5) | | | — | | | Total finite-lived intangible assets | | 11,066 | | | (2,287) | | | 8,779 | | | Indefinite-lived intangible assets | | 49 | | | — | | | 49 | | | Total intangible assets | | $ | 11,115 | | | $ | (2,287) | | | $ | 8,828 | |
|
| Schedule of Estimated Amortization Expense of Intangible Asset |
As of December 31, 2024, the estimated future amortization expense of intangible assets with determinable lives was as follows: | | | | | | | | | | | Amount | | | (in thousands) | | 2025 | | $ | 2,067 | | | 2026 | | 1,360 | | | 2027 | | 1,209 | | | 2028 | | 632 | | | 2029 | | 592 | | | Thereafter | | 729 | | Total | | $ | 6,589 | |
|